Literature DB >> 20719982

Polycystic kidney disease in Han:SPRD Cy rats is associated with elevated expression and mislocalization of SamCystin.

Shizuko Nagao1, Miwa Morita, Masanori Kugita, Daisuke Yoshihara, Tamio Yamaguchi, Hiroki Kurahashi, James P Calvet, Darren P Wallace.   

Abstract

Polycystic kidney disease (PKD) in Han:SPRD Cy rats is caused by a missense mutation in Anks6 (also called Pkdr1), leading to an R823W substitution in SamCystin, a protein that contains ankyrin repeats and a sterile alpha motif (SAM). The cellular function of SamCystin and the role of the Cy (R823W) mutation in cyst formation are unknown. In normal SPRD rats, SamCystin was found to be expressed in proximal tubules and glomeruli; protein expression was highest at 7 days of age and declined by ∼50-60% at 45-84 days of age. In Cy/+ and Cy/Cy kidneys, expression of SamCystin was lower than in +/+ kidneys at 3 and 7 days but became elevated at 21 days. Immunohistochemical analysis revealed that SamCystin was distributed on the brush border of proximal tubules in normal rat kidneys. In Cy/+ kidneys, there were robust SamCystin staining in cyst-lining epithelial cells and loss of apical localization, and increased number of PCNA-positive cells in cyst-lining epithelia. Verapamil, an L-type Ca(2+) channel blocker, accelerated PKD progression in this model and caused a further increase in the expression and abnormal distribution of SamCystin. We conclude that aberrant expression and mislocalization of R823W SamCystin lead to increased cell proliferation and renal cyst formation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20719982      PMCID: PMC2980402          DOI: 10.1152/ajprenal.00504.2009

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  33 in total

1.  SAM domains: uniform structure, diversity of function.

Authors:  Chongwoo A Kim; James U Bowie
Journal:  Trends Biochem Sci       Date:  2003-12       Impact factor: 13.807

Review 2.  Genetics and pathogenesis of polycystic kidney disease.

Authors:  Peter Igarashi; Stefan Somlo
Journal:  J Am Soc Nephrol       Date:  2002-09       Impact factor: 10.121

3.  Positional cloning of jcpk/bpk locus of the mouse.

Authors:  Cathy Cogswell; Sarah J Price; Xiaoying Hou; Lisa M Guay-Woodford; Lorraine Flaherty; Elizabeth C Bryda
Journal:  Mamm Genome       Date:  2003-04       Impact factor: 2.957

4.  Closely linked polymorphic markers for determining the autosomal dominant allele (Cy) in rat polycystic kidney disease.

Authors:  S Nagao; T Ushijima; M Kasahara; T Yamaguchi; M Kusaka; J Matsuda; M Nagao; H Takahashi
Journal:  Biochem Genet       Date:  1999-08       Impact factor: 1.890

5.  Polycystin-2 is an intracellular calcium release channel.

Authors:  Peter Koulen; Yiqiang Cai; Lin Geng; Yoshiko Maeda; Sayoko Nishimura; Ralph Witzgall; Barbara E Ehrlich; Stefan Somlo
Journal:  Nat Cell Biol       Date:  2002-03       Impact factor: 28.824

6.  Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist.

Authors:  Vincent H Gattone; Xiaofang Wang; Peter C Harris; Vicente E Torres
Journal:  Nat Med       Date:  2003-09-21       Impact factor: 53.440

Review 7.  Lillian Jean Kaplan International Prize for advancement in the understanding of polycystic kidney disease. Understanding polycystic kidney disease: a systems biology approach.

Authors:  Jared J Grantham
Journal:  Kidney Int       Date:  2003-10       Impact factor: 10.612

8.  Cyclic AMP activates B-Raf and ERK in cyst epithelial cells from autosomal-dominant polycystic kidneys.

Authors:  Tamio Yamaguchi; Shizuko Nagao; Darren P Wallace; Franck A Belibi; Benjamin D Cowley; Jill C Pelling; Jared J Grantham
Journal:  Kidney Int       Date:  2003-06       Impact factor: 10.612

9.  The polycystic kidney disease-related proteins Bicc1 and SamCystin interact.

Authors:  Emily E Stagner; Denise J Bouvrette; Jianlin Cheng; Elizabeth C Bryda
Journal:  Biochem Biophys Res Commun       Date:  2009-03-24       Impact factor: 3.575

10.  Effective treatment of an orthologous model of autosomal dominant polycystic kidney disease.

Authors:  Vicente E Torres; Xiaofang Wang; Qi Qian; Stefan Somlo; Peter C Harris; Vincent H Gattone
Journal:  Nat Med       Date:  2004-02-29       Impact factor: 53.440

View more
  14 in total

1.  Directed differentiation of human pluripotent cells to ureteric bud kidney progenitor-like cells.

Authors:  Yun Xia; Emmanuel Nivet; Ignacio Sancho-Martinez; Thomas Gallegos; Keiichiro Suzuki; Daiji Okamura; Min-Zu Wu; Ilir Dubova; Concepcion Rodriguez Esteban; Nuria Montserrat; Josep M Campistol; Juan Carlos Izpisua Belmonte
Journal:  Nat Cell Biol       Date:  2013-11-17       Impact factor: 28.824

2.  Kidney Disease Progression Does Not Decrease Intestinal Phosphorus Absorption in a Rat Model of Chronic Kidney Disease-Mineral Bone Disorder.

Authors:  Colby J Vorland; Annabel Biruete; Pamela J Lachcik; Shruthi Srinivasan; Neal X Chen; Sharon M Moe; Kathleen M Hill Gallant
Journal:  J Bone Miner Res       Date:  2019-11-15       Impact factor: 6.741

3.  Crystal deposition triggers tubule dilation that accelerates cystogenesis in polycystic kidney disease.

Authors:  Jacob A Torres; Mina Rezaei; Caroline Broderick; Louis Lin; Xiaofang Wang; Bernd Hoppe; Benjamin D Cowley; Vincenzo Savica; Vicente E Torres; Saeed Khan; Ross P Holmes; Michal Mrug; Thomas Weimbs
Journal:  J Clin Invest       Date:  2019-07-30       Impact factor: 14.808

4.  The SAM domain of ANKS6 has different interacting partners and mutations can induce different cystic phenotypes.

Authors:  Zeineb Bakey; Marie-Thérèse Bihoreau; Rémi Piedagnel; Laure Delestré; Catherine Arnould; Alexandre d'Hotman de Villiers; Olivier Devuyst; Sigrid Hoffmann; Pierre Ronco; Dominique Gauguier; Brigitte Lelongt
Journal:  Kidney Int       Date:  2015-06-03       Impact factor: 10.612

5.  L-type calcium channel modulates cystic kidney phenotype.

Authors:  Xingjian Jin; Brian S Muntean; Munaf S Aal-Aaboda; Qiming Duan; Jing Zhou; Surya M Nauli
Journal:  Biochim Biophys Acta       Date:  2014-06-09

6.  Loss of Anks6 leads to YAP deficiency and liver abnormalities.

Authors:  Merlin Airik; Markus Schüler; Blake McCourt; Anna-Carina Weiss; Nathan Herdman; Timo H Lüdtke; Eugen Widmeier; Donna B Stolz; Kari N Nejak-Bowen; Dean Yimlamai; Yijen L Wu; Andreas Kispert; Rannar Airik; Friedhelm Hildebrandt
Journal:  Hum Mol Genet       Date:  2020-11-04       Impact factor: 6.150

7.  Inhibition of Comt with tolcapone slows progression of polycystic kidney disease in the more severely affected PKD/Mhm (cy/+) substrain of the Hannover Sprague-Dawley rat.

Authors:  Susanne N E Boehn; Sonja Spahn; Sabine Neudecker; Andrea Keppler; Marie-Thérèse Bihoreau; Bettina Kränzlin; Priyanka Pandey; Sigrid C Hoffmann; Li Li; Vicente E Torres; Hermann-Josef Gröne; Norbert Gretz
Journal:  Nephrol Dial Transplant       Date:  2013-03-29       Impact factor: 5.992

8.  An mTOR kinase inhibitor slows disease progression in a rat model of polycystic kidney disease.

Authors:  Kameswaran Ravichandran; Iram Zafar; Abdullah Ozkok; Charles L Edelstein
Journal:  Nephrol Dial Transplant       Date:  2014-09-19       Impact factor: 5.992

9.  Calcitriol Suppression of Parathyroid Hormone Fails to Improve Skeletal Properties in an Animal Model of Chronic Kidney Disease.

Authors:  Christopher L Newman; Nannan Tian; Max A Hammond; Joseph M Wallace; Drew M Brown; Neal X Chen; Sharon M Moe; Matthew R Allen
Journal:  Am J Nephrol       Date:  2016-02-17       Impact factor: 3.754

Review 10.  Vascular Calcification in Rodent Models-Keeping Track with an Extented Method Assortment.

Authors:  Jaqueline Herrmann; Manasa Reddy Gummi; Mengdi Xia; Markus van der Giet; Markus Tölle; Mirjam Schuchardt
Journal:  Biology (Basel)       Date:  2021-05-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.